Market Research Logo

Hungary Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Despite recent improvements in healthcare outcomes in Hungary, the country remains far frombridging the gap with its Western European counterparts. The most prominent reason behind this is the lackof funding within the healthcare system - a factor that is holding back emerging European healthcaresystems as a whole. Ultimately, this will limit drugmaker opportunities in Hungary due to poor access toinnovative medicines.

Headline Expenditure Projections

Pharmaceuticals: HUF731bn (USD2.60bn) in 2016 to HUF763bn (USD2.71bn) in 2017; +4.3% in localcurrency terms and 4.3% in US dollar terms. Forecast increased from last quarter.

Healthcare: HUF2.63trn (USD9.33bn) in 2016 to HUF2.80trn (USD9.94bn) in 2017; +6.6% in localcurrency terms and 6.5% in US dollar terms. Forecast in US dollar terms revised upwards from lastquarter.

Latest Updates

A report by the State Health Care Centre (ÁEEK) in June 2017 highlighted that 26% of deaths in 2014(approximately 32,000) could have been prevented. The report stated these deathslikely happened due toinefficient use of healthcare funds and underfunding of Hungary's healthcare system.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Hungary 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2013-2021)
Prescription Drug Market
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2013-2021)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2015-2021)
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals: A Mixture Of Opportunities
Regulatory Review
Intellectual Property Issues
Pricing Regime
Table: OEP Reimbursement Changes, September 2014
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Hungary 2011-2016)
Table: Healthcare Personnel (Hungary 2011-2016)
Table: Healthcare Activity (Hungary 2011-2016)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Egis Pharmaceuticals (Servier)
Gedeon Richter
Demographic Forecast
Table: Population Headline Indicators (Hungary 1990-2025)
Table: Key Population Ratios (Hungary 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Hungary 1990-2025)
Table: Population By Age Group (Hungary 1990-2025)
Table: Population By Age Group % (Hungary 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report